03/10/2024 11:15 PM | Evelo Biosciences (Filer)
| Form EFFECT | |
01/26/2024 4:26 PM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/26/2024 4:27 PM | Evelo Biosciences (Filer)
| Form POS AM | |
01/26/2024 4:28 PM | Evelo Biosciences (Filer)
| Form S-8 POS | |
01/26/2024 4:29 PM | Evelo Biosciences (Filer)
| Form S-8 POS | |
01/26/2024 4:30 PM | Evelo Biosciences (Filer)
| Form 15-12G | |
12/27/2023 8:02 AM | Evelo Biosciences (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
|
12/12/2023 6:42 AM | Evelo Biosciences (Filer)
| Form DEF 14A | |
12/12/2023 6:43 AM | Evelo Biosciences (Filer)
| Form DEFA14A | |
12/11/2023 8:09 AM | Evelo Biosciences (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
12/04/2023 5:04 AM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/01/2023 6:11 AM | Evelo Biosciences (Filer)
| Form PRE 14A | |
11/21/2023 5:44 AM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/13/2023 8:02 AM | Evelo Biosciences (Subject) FMR LLC (Filed by)
| Form SC 13G/A | |
11/08/2023 7:31 PM | Evelo Biosciences (Issuer) Thorell Marella (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 7:31 PM | Evelo Biosciences (Issuer) GILL SIMBA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 7:32 PM | Evelo Biosciences (Issuer) McHale Duncan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/08/2023 7:32 PM | Bodmer Mark (Reporting) Evelo Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/27/2023 4:24 PM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 6:05 AM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/13/2023 7:54 PM | Evelo Biosciences (Issuer) McHale Duncan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 7:55 PM | Evelo Biosciences (Issuer) Thorell Marella (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/13/2023 7:55 PM | Bodmer Mark (Reporting) Evelo Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/21/2023 4:25 PM | Evelo Biosciences (Filer)
| Form 424B3 | |
08/21/2023 6:43 AM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/17/2023 11:15 PM | Evelo Biosciences (Filer)
| Form EFFECT | |
08/14/2023 7:14 AM | Evelo Biosciences (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/14/2023 6:42 AM | Evelo Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/10/2023 7:19 AM | Evelo Biosciences (Subject) FMR LLC (Filed by)
| Form SC 13G | |
08/09/2023 7:44 PM | Bodmer Mark (Reporting) Evelo Biosciences (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 7:42 PM | Evelo Biosciences (Issuer) Thorell Marella (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 7:42 PM | Evelo Biosciences (Issuer) McHale Duncan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/09/2023 7:43 PM | Evelo Biosciences (Issuer) GILL SIMBA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |